-
Evotec SE (EVO $4.26)
- $4.26 Cap: $377M
- View EVO Profile
- View Questions on EVO
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Sernova Biotherapeutics Inc. (SVA $0.17)
- $0.17 Cap: $55M
- View SVA Profile
- View Questions on SVA
-
Evotec SE (EVO $4.26)
- $4.26 Cap: $377M
- View EVO Profile
- View Questions on EVO
Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?
Insiders
Share Information
SEC Filings
News and Media